A new study, conducted on more than 140 samples from 12 infected patients, contributes to a better understanding of the dynamics of disease transmiss1
This variant (VB) is considered more virulent and infectious; however, current antiretroviral treatment is effective against it and slows down the pr1
The results show that people with HIV with chronic comorbidities and an unsuppressed HIV viral load could be at greater risk of developing severe COV1
A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy.1
This week the vaccine began to be administered to the first volunteers participating in Phase I/IIa of the trial at the Hospital Trueta in Girona and1
IDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter